PPT-Use of HCV DAAs with HIV Regimens

Author : robaut | Published Date : 2020-09-29

Sam Lam PharmD Annie Vong PharmD 232017 Available HCV treatment DAAs Epclusa sofosbuvir velpatasvir Harvoni sofosbuvir ledipasvir Zepatier grazoprevir

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Use of HCV DAAs with HIV Regimens" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Use of HCV DAAs with HIV Regimens: Transcript

Sam Lam PharmD Annie Vong PharmD 232017 Available HCV treatment DAAs Epclusa sofosbuvir velpatasvir Harvoni sofosbuvir ledipasvir Zepatier grazoprevir . Marie-Louise Vachon, MD, . MSc. Division of . Infectious. . Diseases. Centre Hospitalier Universitaire de Québec. Management of HCV . in Co-Infected Patients. Prevention and counselling. Baseline laboratory testing. Perils and Payoffs of an Outsourced DaaS Initiative. May 8. th. 4:00PM Ballroom E. Paul Stansel. Senior Engineering Advisor. Aetna. Before We Get Started…. Tweet about this session with hashtag . #SYN118 and . AIDS 2016 | 18-22 July 2016 | Durban, South Africa. Babikhina. . Ksenia. «. Treatment Preparedness Coalition. ». office@itpcru.org. . itpcru.org. Monitoring of drug procurement since 2010, HCV procurement since 2012. Learning Objectives. Understand when to switch to a second-line regimen. Know preferred second-line regimens for adults (including pregnant and breastfeeding women), adolescents, and children. Describe common drug resistance mutations and how they influence choosing a second-line regimen. Cathryn. L. Samples, MD, MPH, AAHIVS. Director, Boston HAPPENS. Boston Children’s Hospital. Presented at: Improving . Care for Substance Use, HIV and HCV in Adolescents: . Effective Approaches to Assessing, Treating, and Engaging . Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Amber Wheeler, MD. WIHS Scientific Meeting. June 30, 2014. Objectives. To discuss:. Background . Aims. Preliminary “rough” data. Future Directions. HIV-infected . persons have increased. odds of . Isabelle Andrieux-Meyer, MD. Médecins Sans Frontières . IAS Kuala Lumpur, July 2. nd. 2013. . Prevention strategies for HIV/HCV co infection. Epidemiological burden of HCV/HIV co-infection. Access to HCV screening. 30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 20. Days Since. . Infection. HIV RNA. . (plasma). HIV. . Antibody. HIV p24. . Ag. IgM. IgG. FIGURE . 1: LABORATORY . MARKERS . OF HIV. . INFECTION. Jennifer Stafford, Director Division of Assessment and Accountability Support Monthly DAC Webcast April 11, 2019 1 Welcome Online Testing at High School Assessment and Accountability Updates Questions and Answers Mark Sulkowski, . MD. Professor of Medicine. Medical Director, Viral Hepatitis Center . Johns Hopkins University. Baltimore Maryland USA. Liver disease is the second leading specific causes of death amongst HIV-positive individuals in the D:A:D study. HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. & . Update on HCV . blood bank protocol. . Overview - . diagnostic tests. Serologic . assays: . specific antibody to hepatitis C virus (anti-HCV). Molecular . assays: HCV nucleic acid . (. nucleic. Our Services. Emotional:. Reactions. Feelings about Ourselves & Others. Spiritual:. Values. Self Esteem & Acceptance. Balance & Connection. Physical:. Physical Health. Self-care of Bodies.

Download Document

Here is the link to download the presentation.
"Use of HCV DAAs with HIV Regimens"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.